John Hopkins researcher believes psychedelics can improve memory, MIT publishes controversial study on psychedelics and VR, and Mindset Pharma CEO gives an update.
Could psychedelic medicine help people living with memory loss? Psychology Today spoke with Johns Hopkins School of Medicine researcher Dr. Albert Garcia-Romeu to find out. Here’s what he had to say: https://www.psychologytoday.com/us/blog/american-dementia/202208/could-psychedelic-medicine-help-people-living-memory-loss
It may be a bit controversial, but MIT Review published a piece this week suggesting VR is as good as psychedelics at helping people reach transcendence. According to researchers, on key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms. Here’s more: https://www.technologyreview.com/2022/08/06/1056727/vr-virtual-reality-psychedelics-transcendence/
Mindset Pharma CEO, James Lanthier, issued a letter to shareholders this week, where he provided updates on the company’s intranasal technology using 5-MeO-DMT as well as new partnerships with UK-based Contract Research Organization (“CRO”), Clerkenwell Health and Toronto’s Center for Addiction and Mental Health, a top psychiatric research hospital based in Toronto, Canada. You can read the letter here: https://mindsetpharma.com/mindset-pharma-ceo-james-lanthier-issues-letter-to-shareholders-2/